Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.
Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this aspect.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check36 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference2%
- Check50 days agoChange DetectedSeveral links related to clinical trials and research, including those for Ipilimumab and Nivolumab, have been removed, which may impact access to important study information.SummaryDifference3%
- Check58 days agoChange DetectedThe website has been updated to version 2.12.2, adding new links to clinical trial resources and data fields for downloading study information, while the previous version 2.12.1 has been removed.SummaryDifference4%
- Check72 days agoChange DetectedNew data has been added for locations in Ann Arbor, Michigan, and Amsterdam, Netherlands, while previous entries for Ypsilanti, Michigan, and Amsterdam have been removed, indicating an update in the location tracking.SummaryDifference2%
Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.